| 摘要 |
<p num="1"><br/><br/><br/>The present invention concerns a method for treating platinum-resistant, <br/>ovarian cancer, primary peritoneal carcinoma or fallopian tube carcinoma with <br/>the combination of a HER2 antibody that effectively inhibits HER dimerization <br/>as well as gemcitabine.<br/>
|
